Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nisin Z is a naturally occurring antimicrobial peptide (lantibiotic) produced by the bacterium Lactococcus lactis. It is a variant of the well-known food preservative nisin and differs from the more common Nisin A by a single amino acid substitution (asparagine instead of histidine at position 27). Like other lantibiotics, it contains unusual amino acids such as lanthionine and methyllanthionine formed through posttranslational modification. Nisin Z exhibits broad-spectrum antibacterial activity against Gram-positive bacteria—including Bacillus, Clostridium, Listeria monocytogenes, Staphylococcus—and is used primarily as a natural food preservative to extend shelf life by inhibiting spoilage and pathogenic bacteria. Its mechanism involves depolarization of bacterial cytoplasmic membranes via pore formation. Recent research has also explored its antitumor potential and ability to enhance chemotherapeutic efficacy in cancer models. It has been shown to induce cell death in various cancer cell lines (e.g., non-small cell lung cancer, breast cancer) and may mitigate neuroinflammation associated with Alzheimer’s disease-like pathology[2][10]. Nisin Z is stable under acidic conditions and heat sterilization but insoluble in alkaline environments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nisin z.